Aurora Cannabis (TSX: ACB, NYSE: ACB)
With a market capital of C$9.51 billion and a current share price of C$9.19, Aurora Cannabis is among the top cannabis growers in Canada. The company officially received its ACMPR license to sell in November 2015.
Aurora has made a lot of profits since receiving its license as well as acquiring press for events including its controversial C$1.1 billion acquisition of CanniMed Therapeutics. Aurora has also invested in several marijuana companies, such as The Green Organic Dutchman which is another Canadian firm.
The company recently stated its plans to widen its collection with vapes, concentrates, and edibles. The company also plans on implementing a national awareness campaign to teach cannabis producers and users on how to safely consume these new products.
Cronos Group (TSX: CRON, NASDAQ: CRON)
With a Market capital of C$6.58 billion and current share price of C$19.34, Cronos Group is a Toronto based firm which was established in 2012. This Canadian company has begun distributing its products across five continents. The company acquired three cannabis brands, including PeaceNaturals, its health and wellness brand, as well as Cove and Spinach.
Cronos Group recently made a supply agreement with Pohl-Boskamp, which is a pharmaceutical manufacturer and supplier in Germany. Furthermore, the company has merged with Kibbutz Gan Shmuel; an agricultural producer focused on exporting cannabis to 35 countries.
In Q1 2018, Cronos made waves when it became the first Canadian cannabis stock to list on the NASDAQ. It’s also had made a net revenue was C$6.5 million in its Q1 results for 2019, which is a 120 percent increase from C$2.9 million for the same quarter in 2018.
The company recently agreed to acquire an 84,000 square foot fermentation and production facility in Winnipeg, a microbiology and organic chemistry laboratory, and several other facilities for processing and packaging plants.
Tilray (NASDAQ: TLRY)
With a market capital of US$4.34 billion and current share price of US$44.07, Tilray is a cannabis and pharmaceutical company founded in Nanaimo, BC. It was the first GMP-certified medical marijuana producer to legally export medical cannabis to other continents in the world. Due to the company’s current potential, it has focused on increasing its international base by importing medical marijuana oil into Ireland for the first time for national distribution in July.
In Q1 2019, the company had a net revenue of C$31 million, which is a 195.1 percent increase in revenue compared to the first quarter of 2018. The legalization of cannabis n Canada was another big leap for the company.
HEXO (TSX: HEXO, NYSE: HEXO)
With a market capital of C$1.70 billion and current share price of C$6.72, HEXO is another Canadian cannabis company which focuses on recreational cannabis products such as cannabis oil and dried cannabis flower. Hexo was initially producing medical cannabis products, but the legalization of recreational cannabis in Canada saw the company expand into the business of recreational cannabis.
This year, HEXO agreed with a syndicated credit facility called CIBC and BMO, which will fund various innovative initiatives. The company recently declared the transfer of its common shares from the NYSE American to the New York Stock Exchange, and it listed in stocks in the New York stock exchange since July 16.
However, psilocybin is becoming the new cannabis as shrooms find themselves in therapeutic use. What began as a ritual embibement thousands of years ago, could help doctors treat the human mind non-intrusively with an unheard of efficacy. It is a treatment for depression, cancer related psychological distress and abstaining from smoking. You can buy shrooms in toronto from an online store of different varieties.